These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 18379296)

  • 21. Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences.
    Caivano R; Cirillo P; Balestra A; Lotumolo A; Fortunato G; Macarini L; Zandolino A; Vita G; Cammarota A
    J Med Imaging Radiat Oncol; 2012 Dec; 56(6):606-16. PubMed ID: 23210579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging prostate cancer.
    Jung AJ; Westphalen AC
    Radiol Clin North Am; 2012 Nov; 50(6):1043-59. PubMed ID: 23122037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer.
    Kayhan A; Fan X; Oto A
    Top Magn Reson Imaging; 2009 Apr; 20(2):105-12. PubMed ID: 20010065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
    Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
    Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo prostate magnetic resonance imaging and magnetic resonance spectroscopy at 3 Tesla using a transceive pelvic phased array coil: preliminary results.
    Kim HW; Buckley DL; Peterson DM; Duensing GR; Caserta J; Fitzsimmons J; Blackband SJ
    Invest Radiol; 2003 Jul; 38(7):443-51. PubMed ID: 12821859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Staging and tissue characterization of prostate carcinoma: role of endorectal MR imaging and MR spectroscopy].
    Sugimura K
    Hinyokika Kiyo; 2000 Nov; 46(11):855-9. PubMed ID: 11193312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer.
    Hasumi M; Suzuki K; Taketomi A; Matsui H; Yamamoto T; Ito K; Kurokawa K; Aoki J; Endo K; Yamanaka H
    Anticancer Res; 2003; 23(5b):4223-7. PubMed ID: 14666629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MR imaging of prostate cancer].
    Heuck A; Scheidler J; Sommer B; Graser A; Müller-Lisse UG; Massmann J
    Radiologe; 2003 Jun; 43(6):464-73. PubMed ID: 12827261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion and perfusion MR imaging of the prostate.
    Somford DM; Fütterer JJ; Hambrock T; Barentsz JO
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):685-95, ix. PubMed ID: 18926431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of high-field MR in studies of localized prostate cancer.
    Lagemaat MW; Scheenen TW
    NMR Biomed; 2014 Jan; 27(1):67-79. PubMed ID: 23703839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Magnetic resonance tomography with endorectal coil for examination of prostate and seminal vesicles].
    Rørvik J
    Tidsskr Nor Laegeforen; 2000 Feb; 120(6):689-92. PubMed ID: 10806882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Local staging with magnetic resonance imaging after neoadjuvant hormonal therapy for prostate cancer].
    Nagae H; Sato T; Nagata M; Un-no T; Mugiya S; Ichijo K
    Hinyokika Kiyo; 2001 Sep; 47(9):615-8. PubMed ID: 11692596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.
    Delongchamps NB; Rouanne M; Flam T; Beuvon F; Liberatore M; Zerbib M; Cornud F
    BJU Int; 2011 May; 107(9):1411-8. PubMed ID: 21044250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endorectal magnetic resonance imaging of the prostate and bladder].
    Sugimura Y; Hayashi N; Yamashita A; Kinbara H; Arima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1994 Jan; 40(1):31-6. PubMed ID: 7509118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging and MR spectroscopic imaging of prostate cancer.
    Rajesh A; Coakley FV
    Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):557-79, vii. PubMed ID: 15271371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.
    Villeirs GM; Oosterlinck W; Vanherreweghe E; De Meerleer GO
    Eur J Radiol; 2010 Feb; 73(2):352-6. PubMed ID: 19084363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla.
    Sosna J; Pedrosa I; Dewolf WC; Mahallati H; Lenkinski RE; Rofsky NM
    Acad Radiol; 2004 Aug; 11(8):857-62. PubMed ID: 15354305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future?
    Hussain SM; Wielopolski PA; Martin DR
    Top Magn Reson Imaging; 2005 Jul; 16(4):325-35. PubMed ID: 16785848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI of the prostate: clinical relevance and emerging applications.
    Mazaheri Y; Shukla-Dave A; Muellner A; Hricak H
    J Magn Reson Imaging; 2011 Feb; 33(2):258-74. PubMed ID: 21274967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.